Duke University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Duke University sits in the top decile of US sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count).
Duke University: 1,725 sponsored US clinical trials, 187 recruiting.
Duke University sponsors 1,725 registered US clinical trials on ClinicalTrials.gov, 187 of them currently recruiting, and 1,244 completed. 175 of these trials are in Phase 3-4 (later-stage) and 311 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 15 trials.
Top-decile sponsor footprint
Duke University ranks in the top decile of sponsors by registered trial count (#9 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,244 of 1,444 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,725 total, page 32 of 35
Neuroimaging Decision Making and Response Inhibition During Smoking Abstinence
NCT00672256
Molecular, Genetic, and Genomic Assessments From Patients Treated With RAD001
NCT00636090
Effect of Discontinuation of Sugar Sweetened Beverages
NCT00585897
Diagnostic Yield of Vitreous Biopsy in Sarcoid Uveitis
NCT00609687
Developing Computer Based Treatments for Addiction
NCT00586534
A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments
NCT00586417
Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma
NCT00510887
A Randomized Trial of Remote Monitoring of Implantable Cardioverter Defibrillators Versus Quarterly Device Interrogations in Clinic
NCT00606567
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
NCT00399893
Combining Observational and Physiologic Sedation Assessment Tools
NCT00538369
Functional Brain Imaging of Medication Treatment Response in Mild Alzheimer's Disease Patients
NCT00369603
Exercise Intervention Study for Early-Stage Breast Cancer Patients Receiving Neoadjuvant Therapy.
NCT00405678
Retisert and Cataract Surgery in Patients With Severe Uveitis
NCT00570830
Responses of Myocardial Ischemia to Escitalopram Treatment
NCT00574847
Duke Conte Center for the Neuroscience of Depression in Late Life
NCT00576875
Randomized Controlled Trial of Hyperbaric Oxygen in Patients Who Have Taken Bisphosphonates
NCT00462098
Showing Health Information Value in a Community Network
NCT00365885
Study of the Insomnia in Patients With Low Back Pain
NCT00365976
Treatment of Mood and Marriage Study (TOMMS)
NCT00612807
Exercise to Treat Depression in Individuals With Coronary Heart Disease
NCT00302068
Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy
NCT00672594
Sorafenib in Myelodysplastic Syndrome
NCT00510289
Risk of Developing Antibodies to Heparin-PF4 After Heart Surgery
NCT00237328
Study of an Intervention to Improve Use of Life-saving Medications for Heart Disease
NCT00323258
DepoCyt for Active Lymphomatous or Leukemic Meningitis
NCT00523939
Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease
NCT00324454
Cognitive Behavioral Insomnia Therapy for Individuals With Fibromyalgia
NCT00321451
Zoledronate in Preventing Osteoporosis in Patients With Primary Malignant Glioma
NCT00301873
An Optical Assay System for Intra Operative Assessment of Tumor Margins in Patients
NCT00734955
3-D Transcranial Ultrasound Analysis Study
NCT00239525
Dose-Dense Induction/Neoadjuvant Chemotherapy in Locally Advanced Non-Small Cell Lung Cancer
NCT02157116
Locomotor Experience Applied Post Stroke Trial
NCT00243919
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
NCT00314808
TissueLink Study During Multi-Level Spine Surgery
NCT01300559
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) With Bevacizumab and Irinotecan for Malignant Glioma
NCT00352521
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer
NCT00346229
Functional Brain Imaging and Employment in First-Episode Psychotic Patients Treated With Risperdal
NCT00314613
A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy
NCT00573261
Feasibility of Exercise With Post-Op Lung Cancer Patients
NCT00636571
Study to Prevent Cartilage Damage Following Acute Knee Injury.
NCT00332254
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
NCT00335270
Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)
NCT00615927
Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen
NCT00286871
Optical Spectroscopy During Breast Cancer Surgery and Core Needle Biopsy
NCT00734838
Zonisamide for Weight Reduction in Obese Adults
NCT00275834
Antimicrobial PK in Infants With Suspected or Confirmed Infection
NCT00491426
DNA/RNA Analysis of Blood and Skeletal Muscle in Patients Undergoing Cardiac Resynchronization Therapy (CRT)
NCT00600392
Ph. II Treatment of Adults w Primary Malignant Glioma w Irinotecan + Temozolomide
NCT00616005
Levetiracetam in Post-Traumatic Stress Disorder
NCT00413296
Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder
NCT00299611
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 136 |
| Phase 2 | 175 |
| Phase 3 | 41 |
| Phase 4 | 134 |
Therapeutic Areas
What is open in the Duke University pipeline
187 recruiting of 1,725 indexed (11% open); 1,244 completed (72%).
Phase mix: 175 late (III/IV) vs 311 early (I/II) (early-phase heavy).
Top condition: Obesity (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Duke University: open-pipeline peers nationwide
Peers matched on 1,725 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Duke University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,725 trials (± recruiting share)
- University of California, San Francisco · 1,713 trials · 16% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 11% open enrollment (± trial volume)
- Carnegie Mellon University · 11% recruiting · 37 trials
- CAMC Health System · 11% recruiting · 28 trials
- UConn Health · 11% recruiting · 178 trials
- Hartford Hospital · 11% recruiting · 75 trials
Related
What to do with this Duke University page
1,725 registered trials is a research-attention snapshot, not an endorsement of Duke University or any single study.
- 187 of Duke University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Duke University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Duke University pipeline card: 1,725 registered trials from official public datasets.Report a data error.